Taletrectinib trials for Lung cancer

All Taletrectinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Taletrectinib for Lung cancer

• A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
  NCT06564324 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 29 locations
• Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
  NCT07154706 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 33 locations
• Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases
  NCT07008287 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Taletrectinib for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.